NASDAQ:NEOG - Neogen Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$74.70 -0.01 (-0.01 %)
(As of 05/20/2018 04:00 PM ET)
Previous Close$74.70
Today's Range$73.7950 - $75.00
52-Week Range$45.46 - $75.00
Volume222,423 shs
Average Volume162,553 shs
Market Capitalization$3.85 billion
P/E Ratio86.86
Dividend YieldN/A

About Neogen (NASDAQ:NEOG)

Neogen logoNeogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryHealth Care Supplies


Debt-to-Equity RatioN/A
Current Ratio9.44
Quick Ratio7.37


Trailing P/E Ratio86.86
Forward P/E Ratio65.53
P/E Growth4.35

Sales & Book Value

Annual Sales$361.59 million
Price / Sales10.66
Cash Flow$1.1506 per share
Price / Cash64.92
Book Value$9.28 per share
Price / Book8.05


EPS (Most Recent Fiscal Year)$0.86
Net Income$43.79 million
Net Margins14.82%
Return on Equity11.49%
Return on Assets10.31%


Outstanding Shares51,580,000

Neogen (NASDAQ:NEOG) Frequently Asked Questions

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

When did Neogen's stock split? How did Neogen's stock split work?

Neogen shares split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were distributed to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

How were Neogen's earnings last quarter?

Neogen (NASDAQ:NEOG) issued its quarterly earnings results on Thursday, March, 22nd. The company reported $0.32 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.24 by $0.08. The firm had revenue of $95.90 million for the quarter, compared to analysts' expectations of $97.93 million. Neogen had a net margin of 14.82% and a return on equity of 11.49%. The company's revenue was up 8.5% on a year-over-year basis. During the same quarter last year, the business posted $0.27 earnings per share. View Neogen's Earnings History.

When is Neogen's next earnings date?

Neogen is scheduled to release their next quarterly earnings announcement on Monday, July, 16th 2018. View Earnings Estimates for Neogen.

What price target have analysts set for NEOG?

4 Wall Street analysts have issued 12-month target prices for Neogen's shares. Their predictions range from $60.00 to $65.00. On average, they anticipate Neogen's stock price to reach $62.3333 in the next twelve months. View Analyst Ratings for Neogen.

Who are some of Neogen's key competitors?

Who are Neogen's key executives?

Neogen's management team includes the folowing people:
  • Mr. James L. Herbert, Exec. Chairman (Age 78)
  • Mr. Steven J. Quinlan, VP, CFO, Principal Accounting Officer & Sec. (Age 56)
  • Ms. Terri A. Morrical, VP of Animal Safety Operations (Age 53)
  • Mr. John Edward Adent, Pres & CEO (Age 50)
  • Mr. Rod Poland, Director of Corp. Communications

Has Neogen been receiving favorable news coverage?

News coverage about NEOG stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Neogen earned a coverage optimism score of 0.15 on Accern's scale. They also gave media coverage about the company an impact score of 48.71 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Who are Neogen's major shareholders?

Neogen's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.54%), Wasatch Advisors Inc. (3.87%), New York State Common Retirement Fund (2.02%), King Luther Capital Management Corp (1.86%), PNC Financial Services Group Inc. (1.84%) and Stephens Investment Management Group LLC (1.82%). Company insiders that own Neogen stock include Edward Bradley, G Bruce Papesh, Jack C Parnell, James L Herbert, James P Tobin, Richard E Calk, Jr, Ronald D Green, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Institutional Ownership Trends for Neogen.

Which major investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including Tiverton Asset Management LLC, Millennium Management LLC, Glen Harbor Capital Management LLC, Envestnet Asset Management Inc., Citigroup Inc., Flinton Capital Management LLC, Boston Family Office LLC and Teacher Retirement System of Texas. Company insiders that have sold Neogen company stock in the last year include Edward Bradley, G Bruce Papesh, James L Herbert, Ronald D Green, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Insider Buying and Selling for Neogen.

Which major investors are buying Neogen stock?

NEOG stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Wasatch Advisors Inc., King Luther Capital Management Corp, Stephens Investment Management Group LLC, New York State Common Retirement Fund, Northern Trust Corp, Wells Fargo & Company MN and Dimensional Fund Advisors LP. View Insider Buying and Selling for Neogen.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $74.70.

How big of a company is Neogen?

Neogen has a market capitalization of $3.85 billion and generates $361.59 million in revenue each year. The company earns $43.79 million in net income (profit) each year or $0.86 on an earnings per share basis. Neogen employs 1,413 workers across the globe.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at 517-372-9200 or via email at [email protected]

MarketBeat Community Rating for Neogen (NEOG)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  187 (Vote Outperform)
Underperform Votes:  263 (Vote Underperform)
Total Votes:  450
MarketBeat's community ratings are surveys of what our community members think about Neogen and other stocks. Vote "Outperform" if you believe NEOG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEOG will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Neogen (NASDAQ:NEOG) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Neogen in the last 12 months. Their average twelve-month price target is $62.3333, suggesting that the stock has a possible downside of 16.56%. The high price target for NEOG is $65.00 and the low price target for NEOG is $60.00. There are currently 4 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $62.3333$62.3333$61.3333N/A
Price Target Upside: 16.56% downside5.58% downside3.22% upsideN/A

Neogen (NASDAQ:NEOG) Consensus Price Target History

Price Target History for Neogen (NASDAQ:NEOG)

Neogen (NASDAQ:NEOG) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/26/2018StephensReiterated RatingEqual Weight ➝ Hold$62.00 ➝ $65.00MediumView Rating Details
1/4/2018Roth CapitalSet Price TargetHold$82.00 ➝ $62.00MediumView Rating Details
12/7/2017Craig HallumBoost Price TargetHold$46.50 ➝ $60.00LowView Rating Details
7/14/2017CL KingInitiated CoverageNeutral ➝ NeutralLowView Rating Details
(Data available from 5/20/2016 forward)


Neogen (NASDAQ:NEOG) Earnings History and Estimates Chart

Earnings by Quarter for Neogen (NASDAQ:NEOG)

Neogen (NASDAQ:NEOG) Earnings Estimates

2018 EPS Consensus Estimate: $1.29
2019 EPS Consensus Estimate: $1.30
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.30$0.30$0.30
Q2 20182$0.32$0.34$0.33
Q3 20182$0.31$0.33$0.32
Q4 20182$0.31$0.37$0.34
Q1 20191$0.29$0.29$0.29
Q2 20191$0.31$0.31$0.31
Q3 20191$0.29$0.29$0.29
Q4 20191$0.41$0.41$0.41

Neogen (NASDAQ NEOG) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/16/2018$0.30N/AView Earnings Details
3/22/2018Q3 2018$0.24$0.32$97.93 million$95.90 millionViewListenView Earnings Details
1/3/2018Q2 2018$0.26$0.33$102.46 million$101.80 millionViewListenView Earnings Details
9/19/2017Q1 2018$0.2250$0.2325$94.87 million$95.30 millionViewN/AView Earnings Details
7/18/2017Q4 2017$0.24$0.2423$100.80 million$98.80 millionViewN/AView Earnings Details
3/21/2017Q3 2017$0.2025$0.2003$89.41 million$88.40 millionViewN/AView Earnings Details
12/21/2016Q217$0.21$0.2175$89.23 million$90.72 millionViewN/AView Earnings Details
9/27/2016Q117$0.1950$0.1950$85.98 million$83.65 millionViewListenView Earnings Details
7/19/2016Q416$0.1950$0.1950$86.27 million$90.10 millionViewListenView Earnings Details
3/23/2016Q3$0.1875$0.1650$78.47 million$76.73 millionViewListenView Earnings Details
12/21/2015Q216$0.1950$0.18$77.20 million$79.61 millionViewListenView Earnings Details
9/21/2015Q116$0.2025$0.1875$75.98 million$74.86 millionViewListenView Earnings Details
7/21/2015Q4$0.18$0.1875$76.50 million$78.60 millionViewListenView Earnings Details
3/26/2015Q315$0.1725$0.15$70.60 million$68.40 millionViewN/AView Earnings Details
12/18/2014Q215$0.1650$0.1575$70.33 million$68.46 millionViewN/AView Earnings Details
9/22/2014Q115$0.1725$0.18$70.43 million$67.60 millionViewN/AView Earnings Details
7/22/2014Q414$0.1575$0.15$66.36 million$67.30 millionViewN/AView Earnings Details
3/25/2014Q314$0.1350$0.1350$60.38 million$62.00 millionViewN/AView Earnings Details
12/19/2013Q2$0.1575$0.1275$58.32 million$59.60 millionViewListenView Earnings Details
9/24/2013Q114$0.24$0.24$56.15 million$58.55 millionViewN/AView Earnings Details
7/23/2013Q4 2013$0.2250$0.2175$54.94 million$56.01 millionViewN/AView Earnings Details
3/26/2013Q3 2013$0.2025$0.2025$50.84 million$51.06 millionViewN/AView Earnings Details
12/20/2012Q2 2013$0.2025$0.21$51.14 million$50.74 millionViewN/AView Earnings Details
9/25/2012Q113$0.2025$0.21$51.42 million$49.73 millionViewN/AView Earnings Details
7/24/2012$0.1875$0.1875ViewN/AView Earnings Details
3/27/2012$0.1650$0.1650ViewN/AView Earnings Details
12/22/2011$0.1950$0.1650ViewN/AView Earnings Details
9/27/2011$0.1950$0.1875ViewN/AView Earnings Details
7/26/2011$0.18$0.1875ViewN/AView Earnings Details
3/22/2011$0.1575$0.1575ViewN/AView Earnings Details
1/4/2011$0.1950$0.1950ViewN/AView Earnings Details
9/23/2010Q1 2011$0.12$0.12ViewN/AView Earnings Details
7/20/2010Q4 2010$0.10$0.10ViewN/AView Earnings Details
3/29/2010Q3 2010$0.08$0.08ViewN/AView Earnings Details
12/18/2009Q2 2010$0.10$0.10ViewN/AView Earnings Details
9/24/2009Q1 2010$0.09$0.10ViewN/AView Earnings Details
7/21/2009Q4 2009$0.07$0.08ViewN/AView Earnings Details
3/19/2009Q3 2009$0.07$0.06ViewN/AView Earnings Details
1/6/2009Q2 2009$0.08$0.09ViewN/AView Earnings Details
9/24/2008Q1 2009$0.08$0.08ViewN/AView Earnings Details
7/22/2008Q4 2008$0.07$0.07ViewN/AView Earnings Details
3/25/2008Q3 2008$0.06$0.06ViewN/AView Earnings Details
1/3/2008Q2 2008$0.07$0.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Neogen (NASDAQ:NEOG) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Neogen (NASDAQ NEOG) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.20%
Institutional Ownership Percentage: 73.59%
Insider Trading History for Neogen (NASDAQ:NEOG)
Institutional Ownership by Quarter for Neogen (NASDAQ:NEOG)

Neogen (NASDAQ NEOG) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2018G Bruce PapeshDirectorSell6,000$72.50$435,000.0026,261View SEC Filing  
5/10/2018James L HerbertInsiderSell36,000$71.50$2,574,000.00View SEC Filing  
5/8/2018James L HerbertChairmanSell23,000$71.48$1,644,040.00View SEC Filing  
5/7/2018Steven J QuinlanCFOSell5,000$71.82$359,100.0018,470View SEC Filing  
4/18/2018William T BoehmDirectorSell500$69.84$34,920.0010,480View SEC Filing  
4/16/2018James L HerbertInsiderSell20,000$68.50$1,370,000.001,150,926View SEC Filing  
4/10/2018William T BoehmDirectorSell1,020$67.94$69,298.8010,000View SEC Filing  
4/6/2018Terri A MorricalVPSell14,800$67.78$1,003,144.0044,775View SEC Filing  
3/27/2018Steven J QuinlanCFOSell5,000$66.13$330,650.0015,203View SEC Filing  
3/23/2018Thomas H ReedDirectorSell6,000$62.47$374,820.0019,375View SEC Filing  
2/21/2018James L HerbertInsiderSell25,334$59.32$1,502,812.881,157,591View SEC Filing  
2/21/2018Steven J QuinlanCFOSell2,000$60.15$120,300.0015,470View SEC Filing  
2/20/2018Edward BradleyVPSell7,000$59.60$417,200.0012,735View SEC Filing  
2/16/2018Edward BradleyVPSell4,223$60.00$253,380.0012,735View SEC Filing  
2/15/2018James L HerbertInsiderSell10,000$57.50$575,000.001,163,755View SEC Filing  
1/30/2018Edward BradleyVPSell11,725$60.29$706,900.2521,412View SEC Filing  
1/26/2018Edward BradleyVPSell100$60.00$6,000.0021,412View SEC Filing  
1/26/2018G Bruce PapeshDirectorSell6,000$59.72$358,320.0018,196View SEC Filing  
11/17/2017Edward BradleyVPSell17,824$80.32$1,431,623.6827,212View SEC Filing  
11/13/2017James L HerbertInsiderSell26,000$81.45$2,117,700.00879,430View SEC Filing  
10/31/2017Steven J QuinlanCFOSell4,000$80.26$321,040.0014,103View SEC Filing  
10/9/2017Edward BradleyVPSell20,000$78.60$1,572,000.00View SEC Filing  
10/4/2017Edward BradleyVPSell5,401$78.60$424,518.60View SEC Filing  
10/4/2017James L HerbertInsiderSell14,513$78.32$1,136,658.16View SEC Filing  
10/4/2017Steven J QuinlanCFOSell2,250$78.52$176,670.00View SEC Filing  
9/29/2017James L HerbertInsiderSell10,000$77.06$770,600.00879,212View SEC Filing  
9/28/2017Edward BradleyVPSell20,000$76.79$1,535,800.0041,512View SEC Filing  
9/27/2017Terri A MorricalVPSell11,398$75.01$854,963.9828,185View SEC Filing  
9/25/2017Steven J QuinlanCFOSell2,772$73.54$203,852.8812,875View SEC Filing  
9/20/2017Edward BradleyVPSell38,876$71.28$2,771,081.2883,712View SEC Filing  
9/11/2017Edward BradleyVPSell13,628$70.06$954,777.6871,691View SEC Filing  
9/6/2017Edward BradleyVPSell6,372$70.05$446,358.6075,156View SEC Filing  
8/8/2017Ronald D GreenDirectorSell4,333$68.49$296,767.173,333View SEC Filing  
8/8/2017Steven J QuinlanVPSell4,000$68.68$274,720.0014,103View SEC Filing  
7/27/2017James P TobinDirectorBuy500$64.64$32,320.003,200View SEC Filing  
7/19/2017Edward BradleyVPSell5,000$66.33$331,650.0086,512View SEC Filing  
6/19/2017Edward BradleyVPSell5,000$68.72$343,600.0091,512View SEC Filing  
5/19/2017Edward BradleyVPSell5,000$61.33$306,650.0096,512View SEC Filing  
5/12/2017James L HerbertCEOSell48,469$61.29$2,970,665.01912,105View SEC Filing  
5/11/2017James L HerbertCEOSell8,107$62.01$502,715.07890,319View SEC Filing  
4/27/2017Steven J QuinlanCFOSell2,676$63.68$170,407.6812,779View SEC Filing  
4/6/2017Edward BradleyVPSell21,018$61.54$1,293,447.72101,512View SEC Filing  
1/9/2017Jack C ParnellDirectorSell6,000$66.04$396,240.0016,555View SEC Filing  
1/9/2017Terri A MorricalVPSell27,600$66.12$1,824,912.0055,783View SEC Filing  
1/4/2017Steven J QuinlanCFOSell5,352$66.13$353,927.7615,455View SEC Filing  
12/23/2016Terri A MorricalVPSell21,600$65.79$1,421,064.0061,183View SEC Filing  
11/23/2016James L HerbertCEOSell1,000$62.95$62,950.00886,212View SEC Filing  
11/22/2016Edward BradleyVPSell21,600$61.16$1,321,056.00144,130View SEC Filing  
11/14/2016James L HerbertCEOSell36,000$61.00$2,196,000.00904,212View SEC Filing  
11/14/2016Steven J QuinlanCFOSell3,000$61.28$183,840.0013,103View SEC Filing  
10/3/2016James L HerbertCEOSell12,000$55.22$662,640.00886,045View SEC Filing  
9/30/2016Steven J QuinlanCFOSell3,000$55.15$165,450.0013,103View SEC Filing  
9/29/2016Terri A MorricalVPSell9,600$54.14$519,744.0044,384View SEC Filing  
8/24/2016Richard E. Calk, Jr.COOSell5,425$57.47$311,774.75View SEC Filing  
8/10/2016Jack C ParnellDirectorSell5,000$56.87$284,350.0013,555View SEC Filing  
8/9/2016James L HerbertCEOSell6,068$55.60$337,380.80903,850View SEC Filing  
8/8/2016James L HerbertCEOSell8,619$55.24$476,113.56906,401View SEC Filing  
8/5/2016James L HerbertCEOSell24,070$55.41$1,333,718.70900,539View SEC Filing  
8/4/2016James L HerbertCEOSell8,393$55.13$462,706.09906,175View SEC Filing  
8/1/2016Edward BradleyVPSell20,196$55.60$1,122,897.60126,730View SEC Filing  
5/19/2016Richard T CrowderDirectorSell27,250$48.05$1,309,362.5012,750View SEC Filing  
5/10/2016Jack C ParnellDirectorSell4,000$49.17$196,680.0018,568View SEC Filing  
3/24/2016Steven J QuinlanCFOBuy2,236$44.73$100,016.2810,103View SEC Filing  
3/17/2016James L HerbertCEOSell2,500$49.05$122,625.00View SEC Filing  
3/3/2016James L HerbertCEOSell2,500$50.53$126,325.00View SEC Filing  
2/17/2016James L HerbertCEOSell2,500$48.73$121,825.00View SEC Filing  
2/16/2016James L. HerbertCEOSell31,500$48.02$1,512,630.00893,064View SEC Filing  
2/3/2016James L HerbertCEOSell2,500$51.10$127,750.00View SEC Filing  
1/29/2016Terri A MorricalVPSell4,677$51.13$239,135.0139,583View SEC Filing  
1/28/2016Jack C ParnellDirectorBuy13$50.25$653.2522,568View SEC Filing  
1/19/2016James L HerbertCEOSell2,500$52.19$130,475.00View SEC Filing  
1/4/2016James L HerbertCEOSell7,500$54.24$406,800.00View SEC Filing  
12/17/2015James L HerbertCEOSell2,500$59.21$148,025.00View SEC Filing  
12/3/2015James L HerbertCEOSell7,500$59.02$442,650.00View SEC Filing  
11/17/2015James L HerbertCEOSell2,500$55.57$138,925.00View SEC Filing  
11/13/2015James L. HerbertCEOSell36,000$54.41$1,958,760.00897,782View SEC Filing  
11/6/2015Edward BradleyVPSell15,700$55.62$873,234.00122,530View SEC Filing  
11/5/2015Edward BradleyVPSell20,000$55.50$1,110,000.00138,230View SEC Filing  
11/4/2015Edward BradleyVPSell24,300$55.97$1,360,071.00158,230View SEC Filing  
11/3/2015James L HerbertCEOSell7,500$54.31$407,325.00View SEC Filing  
10/19/2015James L HerbertCEOSell2,500$48.40$121,000.00View SEC Filing  
10/5/2015James L HerbertCEOSell2,500$45.47$113,675.00View SEC Filing  
9/22/2015Steven J QuinlanCFOBuy1,060$47.17$50,000.207,867View SEC Filing  
9/22/2015Thomas H ReedDirectorBuy4,000$47.80$191,200.005,131View SEC Filing  
9/17/2015James L HerbertCEOSell7,500$54.11$405,825.00View SEC Filing  
9/3/2015James L HerbertCEOSell2,500$51.15$127,875.00View SEC Filing  
8/24/2015Edward BradleyVPSell5,100$51.00$260,100.00182,530View SEC Filing  
8/24/2015James L. HerbertCEOSell11,148$51.36$572,561.28897,782View SEC Filing  
8/17/2015G Bruce PapeshDirectorSell6,750$54.32$366,660.00View SEC Filing  
8/17/2015James L HerbertCEOSell2,500$57.71$144,275.00View SEC Filing  
7/22/2015James L HerbertCEOSell10,000$59.29$592,900.00View SEC Filing  
7/22/2015Steven J QuinlanCFOSell4,500$59.76$268,920.00View SEC Filing  
7/22/2015Terri A MorricalVPSell19,051$58.61$1,116,579.11View SEC Filing  
7/22/2015Thomas H ReedDirectorSell4,000$61.99$247,960.00View SEC Filing  
6/1/2015James L HerbertCEOSell5,000$46.83$234,150.00View SEC Filing  
4/22/2015James L HerbertCEOSell26,000$47.01$1,222,260.00View SEC Filing  
4/20/2015Richard E Calk JrCOOBuy5,425$45.84$248,682.00View SEC Filing  
4/1/2015James L HerbertCEOSell5,000$45.68$228,400.00View SEC Filing  
3/30/2015Edward BradleyVPSell44,372$47.02$2,086,371.44View SEC Filing  
2/19/2015Steven J QuinlanCFOSell1,500$48.70$73,050.00View SEC Filing  
1/2/2015G Bruce PapeshDirectorSell6,750$48.71$328,792.50View SEC Filing  
10/31/2014Terri A MorricalVPSell10,000$44.05$440,500.00View SEC Filing  
8/28/2014James L HerbertCEOSell14,829$41.98$622,521.42View SEC Filing  
8/25/2014Edward BradleyVPSell7,198$43.39$312,321.22View SEC Filing  
7/29/2014James L HerbertCEOSell10,000$44.17$441,700.00View SEC Filing  
4/1/2014Edward BradleyVPSell41,022$45.13$1,851,322.86182,530View SEC Filing  
3/26/2014Terri MorricalVPSell13,950$45.37$632,911.5042,862View SEC Filing  
2/7/2014James HerbertCEOSell25,000$39.57$989,250.00890,113View SEC Filing  
11/21/2013Steven QuinlanCFOSell1,500$48.82$73,230.005,876View SEC Filing  
11/15/2013James HerbertCEOSell17,720$46.61$825,929.20890,813View SEC Filing  
11/13/2013James HerbertCEOSell10,000$46.52$465,200.00908,533View SEC Filing  
11/12/2013Clayton YeutterDirectorSell1,000$46.91$46,910.00View SEC Filing  
11/12/2013James HerbertCEOSell10,000$46.90$469,000.00918,533View SEC Filing  
11/12/2013Lon BohannonCOOSell14,080$46.89$660,211.2056,524View SEC Filing  
11/11/2013Lon BohannonCOOSell7,520$47.63$358,177.6070,604View SEC Filing  
11/6/2013Clayton YeutterDirectorSell1,000$47.83$47,830.00View SEC Filing  
10/10/2013Edward BradleyVPSell9,380$61.03$572,461.40121,687View SEC Filing  
8/21/2013Lon M BohannonCOOSell7,799$54.24$423,017.76View SEC Filing  
8/20/2013Edward BradleyVPSell4,499$53.80$242,046.20View SEC Filing  
8/20/2013James L HerbertCEOSell8,002$53.95$431,707.90View SEC Filing  
8/15/2013Terri A MorricalVPSell4,349$56.46$245,544.54View SEC Filing  
8/13/2013Lon M BohannonCOOSell22,000$57.10$1,256,200.00View SEC Filing  
8/9/2013Lon M BohannonCOOSell23,447$57.26$1,342,575.22View SEC Filing  
8/5/2013Lon M BohannonCOOSell28,304$57.31$1,622,102.24View SEC Filing  
8/1/2013Lon M BohannonCOOSell23,127$56.85$1,314,769.95View SEC Filing  
7/31/2013Lon M BohannonCOOSell25,252$56.56$1,428,253.12View SEC Filing  
7/30/2013James L HerbertCEOSell15,295$56.16$858,967.20View SEC Filing  
7/29/2013Lon M BohannonCOOSell10,546$56.80$599,012.80View SEC Filing  
7/26/2013Lon M BohannonInsiderSell12,771$57.22$730,756.62View SEC Filing  
5/9/2013Jack C ParnellDirectorSell3,619$52.50$189,997.50View SEC Filing  
12/28/2012Lon M BohannonCOOSell15,576$44.88$699,050.88View SEC Filing  
12/28/2012Terri A MorricalVPSell8,600$44.81$385,366.00View SEC Filing  
12/27/2012Lon M BohannonCOOSell20,594$45.75$942,175.50View SEC Filing  
12/26/2012Lon M BohannonCOOSell25,916$45.54$1,180,214.64View SEC Filing  
10/18/2012A. Charles FischerDirectorBuy1,000$42.49$42,490.00View SEC Filing  
10/4/2012James L HerbertCEOSell15,000$42.81$642,150.00View SEC Filing  
8/9/2012Lon M BohannonCOOSell21,601$39.17$846,111.17View SEC Filing  
8/8/2012Terri A MorricalVPSell2,551$39.97$101,963.47View SEC Filing  
(Data available from 1/1/2013 forward)


Neogen (NASDAQ NEOG) News Headlines

Neogen (NEOG) Director Sells $435,000.00 in StockNeogen (NEOG) Director Sells $435,000.00 in Stock - May 18 at 1:33 PM
Head-To-Head Analysis: Neogen (NEOG) & Quidel (QDEL)Head-To-Head Analysis: Neogen (NEOG) & Quidel (QDEL) - May 17 at 10:41 AM
Neogen (NEOG) Receives Consensus Rating of "Hold" from AnalystsNeogen (NEOG) Receives Consensus Rating of "Hold" from Analysts - May 15 at 10:59 AM
$107.83 Million in Sales Expected for Neogen (NEOG) This Quarter$107.83 Million in Sales Expected for Neogen (NEOG) This Quarter - May 14 at 2:10 AM
$0.30 EPS Expected for Neogen (NEOG) This Quarter$0.30 EPS Expected for Neogen (NEOG) This Quarter - May 12 at 9:18 PM
Trinity Biotech (TRIB) and Neogen (NEOG) Head to Head ReviewTrinity Biotech (TRIB) and Neogen (NEOG) Head to Head Review - May 12 at 9:06 PM
Neogen (NEOG) Chairman James L. Herbert Sells 23,000 SharesNeogen (NEOG) Chairman James L. Herbert Sells 23,000 Shares - May 10 at 10:32 PM
James L. Herbert Sells 36,000 Shares of Neogen (NEOG) StockJames L. Herbert Sells 36,000 Shares of Neogen (NEOG) Stock - May 10 at 10:14 PM
Neogen (NEOG) CFO Sells $359,100.00 in StockNeogen (NEOG) CFO Sells $359,100.00 in Stock - May 9 at 10:12 AM
Analyzing Neogen (NEOG) & Achieve Life Sciences (ACHV)Analyzing Neogen (NEOG) & Achieve Life Sciences (ACHV) - May 8 at 11:26 PM
Head-To-Head Survey: Neogen (NEOG) vs. Achieve Life Sciences (ACHV)Head-To-Head Survey: Neogen (NEOG) vs. Achieve Life Sciences (ACHV) - May 8 at 1:16 AM
$107.60 Million in Sales Expected for Neogen (NEOG) This Quarter$107.60 Million in Sales Expected for Neogen (NEOG) This Quarter - April 27 at 3:50 AM
Breakout Watch: This Medical Stock Is Outperforming 99% Of All StocksBreakout Watch: This Medical Stock Is Outperforming 99% Of All Stocks - April 26 at 4:03 PM
$0.30 Earnings Per Share Expected for Neogen (NEOG) This Quarter$0.30 Earnings Per Share Expected for Neogen (NEOG) This Quarter - April 25 at 11:19 AM
William T. Boehm Sells 500 Shares of Neogen (NEOG) StockWilliam T. Boehm Sells 500 Shares of Neogen (NEOG) Stock - April 20 at 1:21 PM
Neogen (NEOG) Given Average Rating of "Hold" by AnalystsNeogen (NEOG) Given Average Rating of "Hold" by Analysts - April 20 at 8:50 AM
Form 4 NEOGEN CORP For: Apr 16 Filed by: HERBERT JAMES LForm 4 NEOGEN CORP For: Apr 16 Filed by: HERBERT JAMES L - April 19 at 10:02 AM
Neogen names Donofrio VP of Food Safety R&DNeogen names Donofrio VP of Food Safety R&D - April 19 at 10:02 AM
James L. Herbert Sells 20,000 Shares of Neogen (NEOG) StockJames L. Herbert Sells 20,000 Shares of Neogen (NEOG) Stock - April 18 at 7:13 PM
Neogen (NEOG) Director Sells $69,298.80 in StockNeogen (NEOG) Director Sells $69,298.80 in Stock - April 11 at 7:27 PM
Neogen (NEOG) Stock Rating Upgraded by BidaskClubNeogen (NEOG) Stock Rating Upgraded by BidaskClub - April 10 at 9:26 PM
Is Neogen Corporation’s (NASDAQ:NEOG) Liquidity Good Enough?Is Neogen Corporation’s (NASDAQ:NEOG) Liquidity Good Enough? - April 10 at 4:01 PM
Neogen (NEOG) Expected to Announce Quarterly Sales of $107.60 MillionNeogen (NEOG) Expected to Announce Quarterly Sales of $107.60 Million - April 10 at 3:33 AM
Terri A. Morrical Sells 14,800 Shares of Neogen (NEOG) StockTerri A. Morrical Sells 14,800 Shares of Neogen (NEOG) Stock - April 9 at 10:26 PM
Neogen chairman to gift stockNeogen chairman to gift stock - April 6 at 11:52 AM
Hagedorn named Neogen VP of food safety operationsHagedorn named Neogen VP of food safety operations - April 6 at 10:42 AM
Neogen Traded at a 52-Week High on March 28: What’s Behind It?Neogen Traded at a 52-Week High on March 28: What’s Behind It? - April 4 at 5:34 PM
Neogen (NEOG) Upgraded by ValuEngine to BuyNeogen (NEOG) Upgraded by ValuEngine to Buy - April 3 at 11:04 AM
Zacks Investment Research Downgrades Neogen (NEOG) to HoldZacks Investment Research Downgrades Neogen (NEOG) to Hold - April 2 at 5:52 PM
Neogen (NEOG) Cut to "Hold" at Zacks Investment ResearchNeogen (NEOG) Cut to "Hold" at Zacks Investment Research - March 29 at 10:55 AM
Neogen (NEOG) Rating Lowered to Hold at BidaskClubNeogen (NEOG) Rating Lowered to Hold at BidaskClub - March 28 at 9:16 PM
Zacks Investment Research Upgrades Neogen (NEOG) to BuyZacks Investment Research Upgrades Neogen (NEOG) to Buy - March 28 at 9:33 AM
Insider Selling: Neogen (NEOG) CFO Sells 5,000 Shares of StockInsider Selling: Neogen (NEOG) CFO Sells 5,000 Shares of Stock - March 27 at 10:32 PM
Neogen (NEOG) Director Sells $374,820.00 in StockNeogen (NEOG) Director Sells $374,820.00 in Stock - March 27 at 10:23 AM
Stephens Reaffirms Hold Rating for Neogen (NEOG)Stephens Reaffirms Hold Rating for Neogen (NEOG) - March 26 at 4:18 PM
Neogen (NEOG) Q3 Earnings Beat, Revenues Miss EstimatesNeogen (NEOG) Q3 Earnings Beat, Revenues Miss Estimates - March 26 at 10:35 AM
Neogen (NEOG) Given Consensus Recommendation of "Hold" by AnalystsNeogen (NEOG) Given Consensus Recommendation of "Hold" by Analysts - March 26 at 7:53 AM
Neogen (NEOG) Expected to Earn Q4 2018 Earnings of $0.31 Per ShareNeogen (NEOG) Expected to Earn Q4 2018 Earnings of $0.31 Per Share - March 26 at 1:36 AM
Edited Transcript of NEOG earnings conference call or presentation 22-Mar-18 3:00pm GMTEdited Transcript of NEOG earnings conference call or presentation 22-Mar-18 3:00pm GMT - March 23 at 9:55 AM
Neogen (NEOG) Announces Quarterly  Earnings ResultsNeogen (NEOG) Announces Quarterly Earnings Results - March 22 at 11:26 AM
Neogen beats by $0.09, misses on revenueNeogen beats by $0.09, misses on revenue - March 22 at 10:15 AM
Neogen reports third quarter resultsNeogen reports third quarter results - March 22 at 10:15 AM
Neogen Corporation to Host Earnings CallNeogen Corporation to Host Earnings Call - March 22 at 10:15 AM
Should You Buy Neogen Corporation (NASDAQ:NEOG) At $64.92?Should You Buy Neogen Corporation (NASDAQ:NEOG) At $64.92? - March 22 at 10:15 AM
Neogen beats 3Q profit forecastsNeogen beats 3Q profit forecasts - March 22 at 10:15 AM
Haemonetics (HAE) vs. Neogen (NEOG) Head to Head ComparisonHaemonetics (HAE) vs. Neogen (NEOG) Head to Head Comparison - March 20 at 9:12 PM
Neogen (NEOG) Lifted to "Strong-Buy" at BidaskClubNeogen (NEOG) Lifted to "Strong-Buy" at BidaskClub - March 17 at 5:00 PM
Neogen (NEOG) Set to Announce Quarterly Earnings on ThursdayNeogen (NEOG) Set to Announce Quarterly Earnings on Thursday - March 15 at 1:20 AM
$97.28 Million in Sales Expected for Neogen Co. (NEOG) This Quarter$97.28 Million in Sales Expected for Neogen Co. (NEOG) This Quarter - March 7 at 2:02 PM
Neogen Co. (NEOG) Shares Sold by Ranger Investment Management L.P.Neogen Co. (NEOG) Shares Sold by Ranger Investment Management L.P. - March 6 at 2:11 PM

SEC Filings

Neogen (NASDAQ:NEOG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Neogen (NASDAQ:NEOG) Income Statement, Balance Sheet and Cash Flow Statement


Neogen (NASDAQ NEOG) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.